-
公开(公告)号：US09572713B2
公开(公告)日：2017-02-21
申请号：US14481961
申请日：2014-09-10
Applicant: NOVARTIS AG
Inventor： Casey Lind , Robert J. Sanchez, Jr.
CPC classification number: A61F9/00781 , A61B3/10 , A61M2205/3344 , A61M2210/0612
Abstract: A method of implanting a treatment device into an eye of a patient comprises inserting a drainage device including a flow system, an inlet tube, and an outlet tube into a subconjunctival space. The inlet tube includes a proximal end coupled to the flow system in the subconjunctival space. The method includes passing a distal end of the inlet tube through a pars plana into a posterior segment of the eye.
Abstract translation: 将治疗装置植入患者眼睛的方法包括将包括流动系统，入口管和出口管的排液装置插入结膜下空间。 入口管包括联接到结膜下空间中的流动系统的近端。 该方法包括将入口管的远端通过平面图延伸到眼睛的后段中。
-
公开(公告)号：US09345619B2
公开(公告)日：2016-05-24
申请号：US14481990
申请日：2014-09-10
Applicant: NOVARTIS AG
Inventor： Andrew Johnson , Casey Lind
CPC classification number: A61F9/00781
Abstract: Described herein is a method of implanting a glaucoma drainage device in an eye having a vitreous chamber and a drainage site. The glaucoma drainage device comprises a tube including a lumen extending from an inlet end to an outlet end, and includes a control element that regulates the amount of fluid flow through the glaucoma drainage device. The method comprises implanting the glaucoma drainage device into pars plana tissue from the vitreous chamber, such that the device extends between the vitreous chamber and the drainage site.
Abstract translation: 本文描述了将青光眼引流装置植入具有玻璃体腔和排水部位的眼睛中的方法。 青光眼引流装置包括管，其包括从入口端延伸到出口端的内腔，并且包括调节通过青光眼引流装置的流体流量的控制元件。 该方法包括将青光眼引流装置植入玻璃体腔的平面组织中，使得该装置在玻璃体腔和排水部位之间延伸。
-
公开(公告)号：US09603742B2
公开(公告)日：2017-03-28
申请号：US14208237
申请日：2014-03-13
Applicant: Novartis AG
Inventor： Robert Sanchez , Casey Lind
CPC classification number: A61F9/00781 , A61B5/036 , A61B2560/0257
Abstract: A system for implantation in an eye of a patient includes a flow device sized for implantation into the eye of the patient. The flow device includes a fluid flow passageway and a flow system. The flow system may include a regulator having a magnetic element, and may be displaceable in the fluid flow passageway to affect flow through the fluid flow passageway. The system may also include a control device physically separate from the flow device and configured to be disposed outside the eye, the control device comprising an actuator magnetic field generator configured to act on the magnetic element to adjust the regulator in the flow system to selectively adjust flow through the flow device in response to changes in intraocular pressure.
-
-
Search Results
3
records
(took 0.014 seconds)
